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Accepted 6 June 2011This study assessed the reuse of norgestomet implants in Nelore cows that were superstimulated
with eCG. In a crossover design trial, eight cows were randomly divided into two experimental
groups and twice superstimulated: Group 1 — half of the cows received a new norgestomet
implant and 2 mg estradiol benzoate (EB) on Day 0; Group 2 — remaining cows received two
once-used norgestomet implants and 2 mg EB also on Day 0. On Day 4 all cows received a single
dose of 2000 IU eCG, and on Day 6 cows were treated with two doses of PGF2α 12 h apart.
Ovulation was induced with 12.5 mg pLH 12 h after implant withdrawal (on Day 7), and ﬁxed-
time artiﬁcial inseminations were carried out 12 and 24 h later. Seven days after pLH injection
embryos were recovered and blood samples were taken to determine circulating progesterone.
Ultrasound examinations were performed at pLH administration and at embryo recovery. The
number of large follicles (≥8 mm) was greater (Pb0.05) in Group 1 (17.1±1.8) than in Group 2
cows (9.7±1.6). Themeannumberof corpora luteawas greater (Pb0.05) forGroup1 (13.8±1.8)
as compared to Group 2 cows (5.4±1.0) and the percentage of large follicles that ovulated
following pLH administration also differed (Pb0.05) between treatments (80.3% and 53.8% for
cows in Groups 1 and 2, respectively). However, no differences (PN0.05) were found between
treatments (respectively, for Group 1 and Group 2 cows) in the follicle diameter (10.5±1.6 and
10.2±1.7 mm), corpus luteum (CL) diameter (15.7±1.8 and 14.4±1.7 mm), CL volume (2232±
1356 and 1893±1828mm3), ova/embryos recovered (6.3±1.1 and 4.0±1.9), transferable
embryos (4.0±1.8 and 2.5±1.0) and plasma progesterone concentration (36.1±8.3 and 35.1±
6.9 ng/mL). In conclusion, the stimulatory effects on the ovaries provided by the use of two once-
used implants were less intense than the ones veriﬁed after using a new implant.
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Embryo transfer (ET) is a reproductive biotechnology used
to multiply the number of animals of high genetic value
(Bó et al., 2004) to accelerate animal genetic improvementy, School of Veterinary
al Reproduction and
, ZIP code 18618-970,
14 3811 6249.
no),
Elsevier OA license.(Nogueira et al., 2002). Superovulatory (SOV) techniques are
involved inETprograms to increaseovulation rate aswell as the
yield of transferable quality embryos (Armstrong, 1993;
González et al., 2001). However, large variation in the SOV
response still remains as a major hindrance to the routine
production of embryos from cattle by conventional methods
(González et al., 2001). Some variation can be attributed to
hormone treatments (Mapletoft et al., 2002). The correlation
between progesterone concentrations and the outcome of the
SOV treatment continues to be a matter of controversy
(reviewed by Britt and Holt, 1988). It is accepted that low
208 M.J. Sudano et al. / Livestock Science 141 (2011) 207–212circulating progesterone proﬁles are negatively related to the
embryo yield and quality (Callesen et al., 1986, 1988; Greve
et al., 1995), and that there is a threshold in progesterone
concentration at several points of the SOV treatment, below
(at follicular wave emergence and just prior embryo recovery)
or above (at estrus) which the SOV response is impaired (Allen
and Foote, 1988; Goto et al., 1987; Herrier et al., 1990).
In spite of strenuous research efforts to circumvent the
variability, there have been few improvements in the super-
ovulation of cattle over the last three decades. The average
number of embryos recovered from superovulated cattle was
4.6 from 248 donors in 1979; 4.8 from 1485 donors in 1999
(Hasler, 2003) and 5.6 from 1192 donors in 2009 (Donaldson
and Perry, 1983). This slight improvement in embryo produc-
tion in the last 10 years occurred due to the use of intravaginal
or subcutaneous progesterone/progestogen releasing devices,
which made possible to initiate superovulation of donor cows
at a random time of the estrous cycle (Mapletoft et al., 1999).
More recently, the reuse of single devices that release
progesterone or analogs to synchronize cows for ﬁxed-time
artiﬁcial insemination (FTAI) or ﬁxed-time embryo transfer
(FTET) have commonly been used (Almeida et al., 2006;
Hernández et al., 2008; Maluf, 2002). However, recent
unpublished results from our lab indicated the occurrence of
breakthrough estrus in cows treated with a single once-used
norgestomet implant. Indeed, 9.9% (8/81) of purebred Nelore
cows exhibited estrus while the once-used implant was still in
situ. This undesirable phenomenon was prevented by using
two once-used implants in beef cows of the same herd.
The efﬁcacy of reusing a progesterone/progestogen releas-
ing device for superovulation of embryo donors has not been
reported. Therefore, this study aimed to evaluate the ovarian
response, embryo recovery and plasma progesterone concen-
tration of Nelore cows subjected to superovulation protocols
based on eCG administration and synchronized with either a
new or two once-used norgestomet implants.
2. Material and methods
2.1. Location, animals and feed
The experiment was conducted at Embrapa Pecuária Sudeste
(latitude 22°01′S; longitude 47°54′W), Southeastern Brazil.
Thelocal weather is tropical, type CwA in accordance with
Köppen's classiﬁcation, characterized by a rainy andhot summer,
and drywinter. Non-lactatingmature Nelore (Bos taurus indicus)
cows (n=8; 7 to 10 years old; 441±19 kg body weight) were
used in this study. All cows were considered sound after
gynecological examination. Cows were managed under an
intensive rotational grazing system based on highly productive
artiﬁcially fertilized tropical pastures. All animals had free access
to mineral supplement and water.
2.2. Experimental design and hormone treatment
In a crossover design trial, cowswere randomly divided into
two groups, and superstimulated twice with 35 days apart in
such a way that any given cow was submitted to both
treatments. Group 1: at a random stage of the estrous cycle,
half of the cows received a new norgestomet implant in the
auricular subcutaneous tissue, containing 3 mg norgestomet(Crestar®, Intervet, São Paulo, Brazil), and 2 mg estradiol
benzoate (Estrogin®, Farmavet Co., São Paulo, Brazil; i.m.) on
Day 0 (7:00). Group 2: the other half of the cows received two
once-used norgestomet implants, which had been previously
used for nine days, and 2 mg EB i.m. (Day 0–7:00). From this
day onwards, superovulation protocol did not differ between
groups. On Day 4 (7:00) all cows received a single dose of
2000 IU eCG i.m. (Folligon®, Intervet) and on Day 6, two i.m.
doses of 150 μg sodium cloprostenol (PGF2α synthetic analog;
Sincrocio®, Ouroﬁno, Ribeirão Preto, Brazil)were administered
12 h apart (7:00 and 19:00). Implants were withdrawn 36 h
after the ﬁrst administration of PGF2α, and 12.5 mg of porcine
LH (Lutropin-V®, Bioniche, São Paulo, Brazil) were adminis-
tered i.m. 12 h after norgestomet implant removal. Cows were
artiﬁcially inseminated twice, each time with a single dose of
frozen semen of proven fertility from the same bull at 12 and
24 h after the administration of pLH (Fig. 1).
2.3. Ovarian ultrasonography
Numbers and diameter of antral follicles and corpora lutea
were assessed by transrectal B-mode ultrasonography of the
ovaries of all cows using a Mindray DP 3300, equipped with a
7.5 MHz transducer (Mindray Bio-medical Eletronics Co, Ltd.,
Shenzhen, China). Ultrasonography examinations were per-
formed as described previously (Kinder et al., 1996). Ovulation
ratewas deﬁned as the proportion of dominant follicles present
on the ovary following superstimulation that ovulated in
response to pLH administration. In Nelore cows, growing
follicles ≥8 mm in diameter were considered large follicles,
morphologically dominant (Mihm et al., 1994) and potentially
pre-ovulatory. Ovaries were assessed on Day 8 (at the time of
pLHadministration) andonDay15 (at embryo recovery),when
ovulation rate was determined. Unovulatory follicles were
deﬁned as large follicles that failed to ovulate after pLH
administration at the embryo recovery (D15). Diameters of
detected corpora lutea were estimated after analyzing frozen
images recorded from the ultrasound to a pen drive. Corpora
lutea volumes were also estimated using the formula:
V=4/3×π×R3, as described by Sartori et al. (2002).
2.4. Embryo recovery
Seven days after the ﬁrst FTAI, embryos were collected
(D15) by a nonsurgical technique (Reichenbach et al., 2001). A
total of sixteen uterine ﬂushes were obtainedwith a phosphate
buffered saline solution (PBS, Nutricell, Campinas, Brazil).
Embryos were graded as transferable embryos (excellent,
good or average morulae and blastocysts), degenerated, or
unfertilized, according to Lindner andWright (1983). The sum
of transferable embryos, degenerated, and unfertilized were
considered as ova/embryos recovered.
2.5. Plasma progesterone concentration
At the time of embryo recovery (D15) blood samples were
taken by jugular venipuncture in heparinized, evacuated tubes.
Samples were kept at 4 °C and centrifuged within 4 h of
collection; plasma was removed and frozen at −20 °C until
assay. Plasma progesterone concentration was determined
using a commercial solid phase radioimmunoassay system
Fig. 1. Hormonal treatments used to induce eCG-based superovulation of Group 1 (one new norgestomet implant) and Group 2 (two once-used norgestomet implant)
Nelore cows.
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California, USA). The intra-assay CV was 5.60%, and the inter-
assay CVs at concentrations of 2.5 and 6.0 ng/mL were 0.7 and
5.3%, respectively. Assay sensitivity was 0.01 ng/mL.
2.6. Statistical analysis
The unpaired t Test with Welch correction was used for the
statistical analysis of continuous dependent variables (follicle
diameter, CL diameter and volume and plasma progesterone
concentration) as well as the discrete dependent variables
(number of large follicles, number of CL, number of ova/embryos
recovered and number of transferable embryos). Ovulation rate
(proportion of dominant follicles present on the ovary following
superstimulation that ovulated in response to pLH administra-
tion)was recorded as a ratio and analyzed through Fisher's exact
test. The signiﬁcance level of 5% (Pb0.05)wasusedand statistical
analyses were performed with the GraphPad InStat 3 software
(Graph Pad Software Inc., San Diego, CA).
3. Results and discussion
Main results are shown in Table 1. Follicle diameter on Day
8, CL diameter, CL volume, plasma progesterone concentration,
number of ova/embryos recovered and transferable embryos
did not differ (PN0.05) between groups (Table 1). However,
once-used implants reduced ovarian response of cows. Indeed,
the number of large follicles and CL, aswell as the ovulation ratein cows from Group 1 was greater than those from Group 2
(Pb0.05; Table 1).
The SOV response is frequently measured by counting the
numbers of CL (Cushmanet al., 1999;Willett et al., 1953). In the
present study, both treatments rendered an intermediate
response (5–14 CL) according to the classiﬁcation presented
by Cushmanet al. (1999). Previous reports described the role of
hormonal treatment on the variation of the response after SOV
challenge (Mapletoft et al., 2002; Martins et al., 2006, 2007;
Murphy et al., 1984). Gonadotropin preparation, source, batch
and biological activity were listed as sources of variation in the
stimulation of ovaries (Murphy et al., 1984). In addition, a large
variability in numbers of ovulations and transferable embryos
has been proved to occur with eCG and other sources of
gonadotropins, even at a constant dose (Elsden et al., 1978).
In this study, mean number of ova/embryos recovered and
transferable embryos was consistent (Table 1) with previous
ﬁndings (Elsden et al., 1978; Monniaux et al., 1983).
Some authors described inconsistent stimulatory effects of
eCG and have related suchmarginal response of eCG to its long
half-life (Murphy and Martinuk, 1991), causing exaggerated
follicular development, failure of ovulation (Gonzalez et al.,
1994; Rubianes et al., 1996; Sudano et al., 2009; Ungerfeld et al.,
1995), with continued follicular growth up to embryo
collection and abnormal endocrine proﬁles coupled with poor
embryo quality (Mikel-Jenson et al., 1982; Saumande et al.,
1978, 1984). In the present study, ovulation failure occurred in
one cow synchronized with two once-used implants, which
Table 1
Superovulation results and plasma progesterone concentration (mean±SE, when applicable) of Nelore cows submitted to an eCG-based superstimulation
protocol with one new or two once-used norgestomet implants.
Group 1
(one new implant, n=8)
Group 2
(two once-used implants, n=8)
Large follicles at LH treatment; n 17.1±1.8a 9.7±1.6b
Follicle diameter at LH treatment; mm 10.5±1.6 10.2±1.7
Corpora lutea at embryo collection; n 13.8±1.8a 5.4±1.0b
Corpus luteum diameter at embryo collection; mm 15.7±1.8 14.4±1.7
Corpus luteum volume at embryo collection; mm3 2232±1356 1893±1828
Ovulation rate; % 80.3a 53.8b
Ova/embryos recovered; n 6.3±1.1 4.0±1.9
Transferable embryos; n 4.0±1.8 2.5±1.0
Plasma progesterone concentration at embryo recovery; ng/mL 36.1±8.3 35.1±6.9
a,bValues with different superscripts in the same row are different (Pb0.05).
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variables as ova/embryos recovered and transferable embryos.
Nevertheless, performance of groups was not different in the
production of embryos.
Protocols combining progestogens and different esters of
estradiol resulted in most synchronous follicular wave emer-
gence and initiate superstimulatory treatments at random
stages of the estrous cycle in cows (Baruselli et al., 2006; Bó
et al., 1995, 2006). Moreover, treatment with pLH 12 h after
norgestomet implant removal synchronized ovulations, allow-
ing for the application of FTAI in superstimulated B. taurus
indicus cattle without the need of estrus detection and with no
interference on the results (Baruselli et al., 2006). Such
associations represented a breakthrough in conventional ET
programs. However, hormonal treatment of SOV protocols is
expensive and replacing FSH with eCG may reduce costs and
labor. Another approach is the reutilization of previously used
progesterone/progestogen releasing devices such as commer-
cial norgestomet implants, which are very popular in Brazilian
beef cattle operations. In the present trial, the combination of
both strategies (i.e., stimulation with eCG and re-use of
implants) allowed for a 19.5% cost reduction related to
superovulation protocol. However, if the calculation is made
based on the cost per transferable embryo recovered, the costs
increased 28.9%.
Norgestomet (17α-acetoxy-11β-methyl-19-norpreg-
4-ene-20, dione) is a modiﬁed 19-norprogesterone (Maluf,
2002). It is a progestogen with stronger biological activity than
natural progesterone (MachadoandKesler, 1996).According to
Machado and Kesler (1996) estrus suppression via the use of
norgestomet silicone implants occurs due to the daily release of
approximately 137–138 μg of norgestomet out of the implant.
In another study, Kesler et al. (1995) showed that the
norgestomet release peak occurs between Day 3 and Day 9,
and that there is also a total release of 2.3 mg of norgestomet
over the 9 days in which the implant remains in situ. Machado
and Kesler (1996) reported that auricular silicone implants
designed to contain 6 mg of norgestomet inserted in beef cows
for 9 days displayed a decrease in the norgestomet load of
2.06 mg.However, there is no report in literature evaluating the
hormone release rate from Crestar® implant, which contains
3 mg of norgestomet with different surface area from the ones
in aforementioned studies. Indeed, some proportion of cows
implantedwith a single once-used devicemay display estrus in
FTAI protocols (unpublished data from our lab). Therefore,comparison between a new and a once-used device was
abandoned and the decision to treat Group 2 cows with two
once-used implants was reinforced. It was postulated that two
once-used implant would have enough norgestomet to keep
cows out of estrus and stimulate changes within the uterine
environmentwhich regulate receptivity and promote embryos'
survival.
Nonetheless, Maluf (2002) assessed the use of one new
implant, one once-used implant or two once-used implants of
norgestomet and obtained no difference on the conception rate
after FTAI for non-lactating (37.5; 34.0 and 39.5%) and lactating
cows (44.0; 35.7 and 32.0%), respectively. Similarly, Almeida
et al. (2006) reported no difference in the conception rate of
cows treatedwith either one new or a once-used implant (48.3
and 48.7%, respectively). Furthermore, Dias et al. (2009)
observed that the pregnancy rate was greater for the third-
use treatment than those for the second-use and ﬁrst-use CIDR
treatments inNelore heifers submitted to FTAI; andClaro Júnior
et al. (2010) reported that a progesterone based treatment
using a previously usedCIDR inB. taurus indicusheifers resulted
in greater follicular diameter, aswell as a higher conception and
pregnancy rates, than the new CIDR treatment. These studies
support the reutilization of previously used progesterone/
progestogen releasing devices for FTAI without difference in
performance or in conception and pregnancy rates. However,
the efﬁcacy of reusing a progesterone/progestogen releasing
device for superovulation of embryo donors observed in the
present study was not as successful as the aforementioned
studies with FTAI. Indeed, there was a signiﬁcant difference in
the superovulation response between a new or two once-used
implants after considering Day 8 large follicles and Day 15 CL
numbers, as well as ovulation rate. However, such difference
did not affect (PN0.05) ova/embryos recovery and transferable
embryos (Table 1); probably because of the limited number of
cows per treatment. Ova/embryos recovery and transferable
embryos were both reduced approximately 37%.
Sanchez et al. (1995) reported that an implant containing
3 mg norgestomet in mature heifers without a corpus luteum
resulted in a typical LH pulse frequency for the follicular phase
(approximately 1 pulse/h). However, two or four norgestomet
implants suppressed LH pulse frequency to that of the luteal
phase (Anderson et al., 1996), supporting the contention that
circulating progesterone concentrationsmodulate LH concentra-
tions and pulsatility and, in turn, growth of the ovulatory follicle
(Adams et al., 1992). Circulating progesterone concentrations are
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oocyte quality (Blondin and Sirard, 1995; Leibfried-Rutledge
et al., 1987; Pfeifer et al., 2005). Several studies have shown that
variations in circulating progesterone concentrations affect
fertility after a synchronized breeding (Carvalho et al., 2008;
Shaham-Albalancy et al., 2000).
Results herein described were in contradiction of the
hypothesis that two once-used norgestomet implant would
have the same SOV response of a single new implant in an
eCG-based superovulation protocol administered to Nelore
cows. The reduced SOV response in the two once-used implant
treatment might be related with an abnormal, erratic, and
lesser norgestomet release pattern which might have allowed
for the emergence of an asynchronic follicular wave within the
induced cycle, a phenomenon which could limit the super-
stimulatory effect of eCG and result in a reduced number of
large follicles.Moreover, the lesser norgestomet release pattern
probably allowed the presence of dominant follicles at the
beginning of the superstimulatory treatment which also
decreased the ovulation rate in Group 2 cows. This is in
agreementwith previous results indicating that the presence of
dominant follicles at the start of superstimulation treatment is
associatedwith a lower ovulation rate in cattle (Guilbault et al.,
1991), primates (Goodman and Hogden, 1983) and ewes
(Driancourt, 1987).
Furthermore, the unovulatory follicles observed at em-
bryo recovery in the two once-used norgestomet implants
group (present in 12.5% of cows) possibly were follicles that
failed to be suppressed following EB administration, which
also reinforced that circulating progesterone was low since
the implant insertion. These observations support the
hypothesis that the ovarian status at the beginning of
treatment accounts for a large portion of the variability in
the superovulatory response (Monniaux et al., 1983).
Despite the greater number of CL (Pb0.05) observed in
cows fromGroup1 onD15, therewasnodifference (PN0.05) in
plasma progesterone concentration between groups. There-
fore, the reason why progesterone reached the same concen-
trations after both treatments is yet to be determined.Maybe, a
possible explanation was that low progesterone concentra-
tions, and consequently high LH pulse–frequency during the
ovulatory wave were associated with overgrowth of the
dominant follicle (Adams et al., 1992), which may improve CL
function (Perry et al., 2007) of cows from Group 2. Moreover,
the large number of CL must be considered in inhibiting
progesterone secretion by luteal tissue from Group 1, i.e.,
greater progesterone concentration caused a down regulation
of progesterone production (Moseley et al., 1979). Similarly,
Garcia-Winder et al. (1988) observed that the use of a new
norgestomet implant in superovulated beef cows reduced
progesterone concentration compared with the untreated
control group.
In conclusion, the administration of two norgestomet
implants, previously used for nine days, was less effective to
superovulate Nelore cows than the use of a new implant.
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